Who gets Prostate cancer?

Mɛ̌ ka nɔ ɖó kansɛ́ɛ́ɛ́ sɛ́n jí tɔn?

Azɔnkwín zò mɛ̀ ɔ́' azɔn è nɔ hu mɛ̀ lɛ́ɛ ɖò tají bɔ̀ azɔ̀n ɔ́ nɔ́ jɛji ɖò xwè jí.

È nɔ mɔ hwɛhwɛ ɖò sunnu e ko ɖó xwè 65 lɛ é mɛ.

Nǔ ɖěɖee sixu zɔ́n bɔ kansɛ́ɛ ɖ'azɔnkɔnkɔnnɔ wú na jɛji lɛ é ɖé lɛ ɖíe:

1. Xwe: Xwe mɛtɔn ko ɖò yiyi wɛ é ɔ, awovinú e nɔ zɔ́n bɔ è nɔ ɖó kansɛ́ɛzɔn e nɔ nyí kancica e nɔ nɔ lanmɛ nú mɛ é é tɔn nɔ ɖò jijɛji wɛ, bɔ sunnu e ɖó xwè 65 jɛji lɛ wɛ nɔ jɛ azɔn enɛ na hugǎn.

2. Xwédo e mɛ è ko mɔ azɔn mɔhun ɖè é: sunnu e sín xwédo mɛ è ko mɔ azɔn mɔhun ɖè lɛ é, ɖò tají ɔ, mɛ e ɖò tɔ́ yetɔn alǒ nɔví yetɔn mɛ bɔ azɔn ɔ ka ko gbò ye lɛ é sixu ɖibla mɔ azɔn mɔhun.

3. akɔ: Azɔnkwín e nɔ hu mɛ ɖò aflika é nɔ hu mɛ e nyí Amɛlika tɔn lɛ é hugǎn, bɔ è nɔ yawu mɔ ye ɖò winnyawinnya mɛ, bɔ azɔn ɔ nɔ syɛn tawun.

4. Nǔ e mɛ e è jì lɛ é nɔ jì lɛ é: Nǔɖe lɛ e è nɔ jì lɛ é, ɖi nǔ e nɔ nyí BRCA1 kpo BRCA2 kpo é sixu zɔ́n bɔ kansɛ́ɛ ɖ'azɔnkɔnkɔn mɛ.

5. Nǔɖuɖu: Nǔɖuɖu e nɔ ɖó lan vɔvɔ kpo nǔ e è nɔ dó anɔ̌nu bɔ ami ɖó é kpo gègě é sixu zɔ́n bɔ kansɛ́ɛ e nɔ ɖó gǒflɛ́mɛ mɛtɔn é na syɛn, bɔ nǔɖuɖu e nɔ ɖó atín kpo mǎ kpo gègě é ka sixu ɖè awovinú ɔ kpò.

6. Jízɛ̀: Jízɛ̀ zɛ xwé wu alǒ kpikpò sixu zɔ́n bɔ è na ɖó kansɛ́ɛ́n e nɔ hu mɛ é, bɔ é sixu lɛ́ syɛn.

7. Nǔ e nɔ zɔ́n bɔ è nɔ zán gbɛ̀ mɛtɔn gbɔn é: Nǔ e nɔ zɔ́n bɔ è nɔ zán gbɛ̀ mɛtɔn gbɔn é ɖé lɛ, ɖi azɔ nunu kpo nǔ e ma nɔ zɔ́n bɔ è nɔ wà nǔ ɖebǔ ǎ é kpo sixu zɔ́n bɔ kansɛ́ɛ e nɔ ɖó gǒflɛ́mɛ mɛtɔn é na syɛn.

É ɖò taji ɖɔ è ni tuùn ɖɔ enyi nǔ enɛ lɛ sixu zɔ́n bɔ kansɛ́n gblegble ɔ tɔn na gblé mɛ ɔ, sunnu e ɖó nǔ enɛ lɛ é bǐ wɛ na jɛ azɔn ɔ ǎ, bɔ sunnu ɖé lɛ tíìn bɔ è tuùn nǔ e sixu zɔ́n bɔ è na gblegble kansɛ́n gblegble ɔ tɔn é ɖě ǎ.

Azɔnkwín e nɔ dó afɔkponɔ lanmɛ nú mɛ é ba dò hwɛhwɛ kpo xóɖiɖɔ dó nǔ ɖebǔ e nɔ ɖu ayi mɛ nú mɛ lɛ é jí kpo sixu d'alɔ bɔ è na mɔ azɔnkwín ɔ ɖò hwenu e è sixu kpéwú bo gbɔ azɔn na é.

['Nǔ ɖevo lɛ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y: Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urol J. 2020, 17 (1): 42-49.

Advanced prostate cancer gets a new foe. Johns Hopkins Med Lett Health After 50. 2013, 25 (7): 8.

Vera Badillo FE: Metastatic prostate cancer gets into the biomarker era. Can Urol Assoc J. 2022, 16 (10): 333.

Gerard MJ, Frank-Stromborg M: Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications. Oncol Nurs Forum. 1998, 25 (9): 1561-9.

McDowell ME, Occhipinti S, Chambers SK: The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior. Health Psychol. 2013, 32 (11): 1158-69.

Razzaghi MR, Mazloomfard MM, Malekian S, Razzaghi Z: Association of macrophage inhibitory factor -173 gene polymorphism with biological behavior of prostate cancer. Urol J. 2019, 16 (1): 32-36.

['Nǔgbɛnúmɛ: dotóoxwé sín']

['Nǔkplɔnkplɔn kpo nǔsisɔ kpo sín azɔ̌ kɛɖɛ wɛ è nɔ wà dó tɛn ɛntɛnɛti tɔn elɔ jí, bo nɔ na wěɖexámɛ dotóoxwé tɔn alǒ azɔ̌ ɖevo lɛ mɛ ǎ.']

['È ɖó na zán nǔ e è kplɔ́n mɛ lɛ é dó ba azɔn ɖé alǒ azɔn ɖé sín wuntun alǒ dó gbɔ na ǎ, bɔ mɛ ɖěɖee jló na ba wěɖexámɛ dotóo tɔn lɛ é ɖó na yì mɔ dotóo e ɖó acɛ bo nɔ wà azɔ̌ ɖò dotóoxwé é ɖé.']

['Mi ni flín ɖɔ nǔ e è nɔ ylɔ ɖɔ "neural net" bo nɔ na xósin nú nǔkanbyɔ lɛ é ɔ, nǔ e nɔ nyí nǔjɛdo tawun é wɛ nyí nǔ ɖěɖee è nɔ ylɔ ɖɔ "numeric content" lɛ é. Ði kpɔ́ndéwú ɔ, mɛ nabi è mɔ azɔn ɖé na é.']

['Nɔ ba wěɖexámɛ dotóo towe tɔn alǒ dotóo ɖevo e ɖó nǔwukpikpé é tɔn dó azɔn ɖé wu hwebǐnu. Ma wɔn wěɖexámɛ dotóo tɔn lɛ gbeɖé ó, alǒ ma lin tamɛ kpɔ́n dó nǔ e a xà ɖò tɛn ɛntɛnɛti tɔn elɔ jí lɛ é wu ó. Enyi a lin ɖɔ azɔn baɖabaɖa ɖé ɖò xwi ɖí xá we wɛ hǔn, ylɔ 911 alǒ yì dotóoxwé e sɛkpɔ we hugǎn é tlolo. Tɛn ɛntɛnɛti tɔn elɔ alǒ nǔ e a nɔ zán lɛ é nɔ zɔ́n bɔ kancica dotóo-azinzɔnnɔ ɖé tɔn nɔ tíìn ǎ. BioMedLib, azɔ̌watɔ́ tɔn lɛ, alǒ mɛ ɖevo ɖebǔ e nɔ wlan nǔ dó tɛn ɛntɛnɛti tɔn elɔ jí lɛ é nɔ ɖè kúnnuɖenú ɖebǔ xlɛ́, bo tlɛ nɔ ɖɔ lɔ ǎ, dó nǔ e è ɖɔ ɖò fí lɛ é alǒ nǔ e è nɔ zán lɛ é wu.']

['Nǔɖògbɛ́jlatɔ́ lɛ']

['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) nɔ na acɛ mɛ e ɖó nǔɖokan yetɔn lɛ é bɔ ye na dó ba nǔɖe bo dó sixu mɔ nǔ e ye ɖó lɛ é ɖò Internet jí.']

["Enyi a ɖi nǔ ɖɔ nǔ ɖĕbǔ ɖò tɛn ɛntɛnɛti tɔn mǐtɔn jí alǒ azɔ̌wiwa mǐtɔn lɛ jí bo hɛn nǔ dó así nú mɛ ɔ, é xò nǔ dó acɛ nǔɖògbɛ́ towe lɛ wu ɔ, hwi (alǒ mɛ e nɔ kpé nukún dó wǔ towe é) sixu sɛ́ wɛn dó mǐ, bo byɔ ɖɔ mǐ ni ɖè nǔ ɖ'emɛ lɛ sín tɛn ɔ jí, alǒ ɖɔ mǐ ni sú ali dó mɛ."]

["È ɖó ná sɛ́ mɛ dó gbɔn email jí (e-mail è nɔ dó ɔ́' kpɔ́n 'Kɔntaktɔ́' ɔ́)."]

['DMCA byɔ ɖɔ ɖɔ nǔ elɔ lɛ ni nɔ akpáxwé nǔ e a ɖɔ é gbà acɛ dó nǔ é tɔn jí é: (1) xó dó azɔ̌ e ɖó acɛ dó nǔ é jí; (2) xó dó nǔ e ɖó acɛ dó nǔ é jí, kpo nǔ ɖevo e na zɔ́n bɔ mǐ na mɔ nǔ ɔ lɛ é kpo; (3) xó dó hwiɖée wu, ɖi adlɛsi towe, alokan towe kpo email towe kpo; (4) xó ɖɔ dó nǔ e wu a ɖi nǔ ɖɔ nǔ e ɖó acɛ dó nǔ e jí a ɖɔ é jí é kún nyí nǔ e ɖó acɛ dó nǔ é jí tɔn ɔ, alǒ mɛ e nɔ kpé nukún dó nǔ é tɔn wu é sín acɛ ó; ']

["(5) Ðɛ́ mɛ̀ è mi sɔ́ alɔ dó ɖ'así ná ɖò hwɛɖɔxɔsá ɔ́' è ɖó ná ɖó hwɛ̀ ɖɔ̀ xó è mi ɖɔ ɖò mɛ̀ è mi dó wèmá ɔ́ mɛ̀ ɔ́' sɔgbe bɔ̀ mi ɖó acɛ̀ bó ná dó ba ɖɔ è ní sú nǔ è è dó wèmá ɔ́ wú lɛ́ɛ sín axɔ́."]

['bɔ (6) alɔ wlanwlan mɛ e ɖó acɛ dó nǔ é tɔn alǒ mɛ e ɖó acɛ bo na wà nǔ dó wutu tɔn é tɔn. ']

['Nú a ma gɔ́ nǔ e ɖò jí lɛ é bǐ ǎ ɔ, é sixu zɔ́n bɔ è na lín có bo na dóhwɛ we.']

['Wǎ kpé mì']

['Mi kɛnklɛn bo sɛ́ nǔkanbyɔ mitɔn lɛ dó mǐ gbɔn e-mail jí.']

Who gets prostate cancer?

Prostate cancer is a disease that primarily affects men, with the risk increasing with age.

It is most commonly diagnosed in men over the age of 65.

Some factors that may increase the risk of developing prostate cancer include:

1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.

2. Family history: Men with a family history of prostate cancer, particularly a father or brother with the disease, have a higher risk of developing prostate cancer themselves.

3. Race: African American men have a higher risk of developing prostate cancer and are more likely to be diagnosed at a younger age and with more aggressive forms of the disease.

4. Genetics: Certain inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, may increase the risk of developing prostate cancer.

5. Diet: A diet high in red meat and high-fat dairy products may increase the risk of prostate cancer, while a diet rich in fruits and vegetables may decrease the risk.

6. Obesity: Being overweight or obese may increase the risk of developing prostate cancer, as well as the likelihood of the cancer being more aggressive.

7. Lifestyle factors: Certain lifestyle factors, such as smoking and lack of physical activity, may increase the risk of developing prostate cancer.

It is important to note that while these factors may increase the risk of developing prostate cancer, not all men with these risk factors will develop the disease, and some men without any known risk factors may still be diagnosed with prostate cancer.

Regular screening and discussing any concerns with a healthcare provider can help to detect prostate cancer early, when it is most treatable.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.